|
1 Company |
|
1 Product |
|
1 Product |
|
2 Mechanisms of Action |
|
0 Trials |
|
14 News |
|
- | Trial completion, Enrollment change, Trial primary completion date: Emergency Treatment of Coral Snake Envenomation With Antivenom (clinicaltrials.gov) - Dec 13, 2017
P3, N=26, Completed, Sponsor: University of Arizona
Active, not recruiting --> Completed | N=55 --> 26 | Trial primary completion date: Nov 2017 --> Nov 2016
- | Trial primary completion date: Emergency Treatment of Coral Snake Envenomation With Antivenom (clinicaltrials.gov) - Apr 13, 2017
P3, N=55, Active, not recruiting, Sponsor: University of Arizona
Active, not recruiting --> Completed | N=55 --> 26 | Trial primary completion date: Nov 2017 --> Nov 2016 Trial primary completion date: Mar 2017 --> Nov 2017
- | Enrollment closed: Emergency Treatment of Coral Snake Envenomation With Antivenom (clinicaltrials.gov) - Apr 4, 2017
P3, N=55, Active, not recruiting, Sponsor: University of Arizona
Trial primary completion date: Mar 2017 --> Nov 2017 Recruiting --> Active, not recruiting
- Trial completion, Trial primary completion date: Comparison of Two Dose Regimens of Snake Antivenom for the Treatment of Snake Bites Envenoming in Nepal (clinicaltrials.gov) - Feb 7, 2017
P2, N=250, Completed, Sponsor: CTU
Recruiting --> Active, not recruiting Active, not recruiting --> Completed | Trial primary completion date: Apr 2013 --> Oct 2012
- Trial completion, Enrollment change, Trial primary completion date: Randomized, Double-Blind, Placebo-Controlled Study: CroFab® vs Placebo for Copperhead Snake Envenomation (clinicaltrials.gov) - Mar 23, 2016
P4, N=76, Completed, Sponsor: BTG International Inc.
Active, not recruiting --> Completed | Trial primary completion date: Apr 2013 --> Oct 2012 Active, not recruiting --> Completed | N=232 --> 76 | Trial primary completion date: Mar 2016 --> Dec 2015
- Trial primary completion date: Emergency Treatment of Coral Snake Envenomation With Antivenom (clinicaltrials.gov) - Mar 8, 2016
P3, N=55, Recruiting, Sponsor: University of Arizona
Active, not recruiting --> Completed | N=232 --> 76 | Trial primary completion date: Mar 2016 --> Dec 2015 Trial primary completion date: Mar 2016 --> Mar 2017
- Trial primary completion date: Randomized, Double-Blind, Placebo-Controlled Study: CroFab® vs Placebo for Copperhead Snake Envenomation (clinicaltrials.gov) - Dec 17, 2015
P4, N=232, Active, not recruiting, Sponsor: BTG International Inc.
Trial primary completion date: Mar 2016 --> Mar 2017 Trial primary completion date: Nov 2015 --> Mar 2016
- Enrollment change, Trial initiation date, Trial termination, Trial primary completion date: Study to Evaluate the Efficacy of Two Treatment Schemes With Antivipmyn ® for the Treatment of Snake Bite Envenomation (clinicaltrials.gov) - Nov 25, 2015
P4, N=10, Terminated, Sponsor: Instituto Bioclon S.A. de C.V.
Trial primary completion date: Nov 2015 --> Mar 2016 N=80 --> 10 | Initiation date: Apr 2008 --> Jan 2008 | Recruiting --> Terminated | Trial primary completion date: Oct 2012 --> Jan 2009; Administrative reasons
- Enrollment closed: Randomized, Double-Blind, Placebo-Controlled Study: CroFab® vs Placebo for Copperhead Snake Envenomation (clinicaltrials.gov) - Nov 17, 2015
P4, N=232, Active, not recruiting, Sponsor: BTG International Inc.
N=80 --> 10 | Initiation date: Apr 2008 --> Jan 2008 | Recruiting --> Terminated | Trial primary completion date: Oct 2012 --> Jan 2009; Administrative reasons Recruiting --> Active, not recruiting
- Trial primary completion date: Randomized, Double-Blind, Placebo-Controlled Study: CroFab® vs Placebo for Copperhead Snake Envenomation (clinicaltrials.gov) - Jun 11, 2015
P4, N=232, Recruiting, Sponsor: BTG International Inc.
Recruiting --> Active, not recruiting Trial primary completion date: Nov 2014 --> Nov 2015
- Enrollment open: Randomized, Double-Blind, Placebo-Controlled Study: CroFab® vs Placebo for Copperhead Snake Envenomation (clinicaltrials.gov) - Sep 25, 2013
P4, N=232, Recruiting, Sponsor: BTG International Inc.
Trial primary completion date: Nov 2014 --> Nov 2015 Not yet recruiting --> Recruiting
- | Enrollment open: Emergency Treatment of Coral Snake Envenomation With Antivenom (clinicaltrials.gov) - Jul 31, 2013
P3, N=55, Recruiting, Sponsor: University of Arizona
Not yet recruiting --> Recruiting Active, not recruiting --> Recruiting
- | New P4 trial: Randomized, Double-Blind, Placebo-Controlled Study: CroFab® vs Placebo for Copperhead Snake Envenomation (clinicaltrials.gov) - May 23, 2013
P4, N=232, Recruiting, Sponsor: BTG International Inc.
- Enrollment change: Copperhead Envenomation Observational Study (clinicaltrials.gov) - May 9, 2013
P=N/A, N=20, Completed, Sponsor: BTG Ltd.
Active, not recruiting --> Recruiting N=30 --> 20
- Trial completion: Copperhead Envenomation Observational Study (clinicaltrials.gov) - May 9, 2013
P=N/A, N=20, Completed, Sponsor: BTG Ltd.
N=30 --> 20 Recruiting --> Completed
- Enrollment closed: Comparison of Two Dose Regimens of Snake Antivenom for the Treatment of Snake Bites Envenoming in Nepal (clinicaltrials.gov) - Dec 11, 2012
P2, N=250, Active, not recruiting, Sponsor: CTU
Recruiting --> Completed Recruiting --> Active, not recruiting
- | Trial initiation date: Emergency Treatment of Coral Snake Envenomation With Antivenom (clinicaltrials.gov) - Mar 26, 2012
P3, N=55, Recruiting, Sponsor: University of Arizona
Recruiting --> Active, not recruiting Initiation date: Jun 2011 --> May 2012
- ||||||| Trial completion: Phase 3 Multicenter Comparative Study to Confirm Safety and Effectiveness of the F(ab)2 Antivenom Anavip. (clinicaltrials.gov) - Jan 8, 2012
P3, N=121, Completed, Sponsor: Instituto Bioclon S.A. de C.V.
Initiation date: Jun 2011 --> May 2012 Recruiting --> Completed